Cargando…
Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690909/ https://www.ncbi.nlm.nih.gov/pubmed/37345485 http://dx.doi.org/10.3324/haematol.2022.281967 |
| _version_ | 1785152622808793088 |
|---|---|
| author | Lee, Julia S. Wagner, Charlotte B. Prelewicz, Stacy Kurish, Heena P. Walchack, Robert Cenin, Danielle A. Patel, Seema Lo, Mimi Schlafer, Danielle Li, Belinda K. T. Donald Harvey III, R. Wasef, Bestis Ying, Jian Kovacsovics, Tibor |
| author_facet | Lee, Julia S. Wagner, Charlotte B. Prelewicz, Stacy Kurish, Heena P. Walchack, Robert Cenin, Danielle A. Patel, Seema Lo, Mimi Schlafer, Danielle Li, Belinda K. T. Donald Harvey III, R. Wasef, Bestis Ying, Jian Kovacsovics, Tibor |
| author_sort | Lee, Julia S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10690909 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106909092023-12-02 Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia Lee, Julia S. Wagner, Charlotte B. Prelewicz, Stacy Kurish, Heena P. Walchack, Robert Cenin, Danielle A. Patel, Seema Lo, Mimi Schlafer, Danielle Li, Belinda K. T. Donald Harvey III, R. Wasef, Bestis Ying, Jian Kovacsovics, Tibor Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-06-22 /pmc/articles/PMC10690909/ /pubmed/37345485 http://dx.doi.org/10.3324/haematol.2022.281967 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Lee, Julia S. Wagner, Charlotte B. Prelewicz, Stacy Kurish, Heena P. Walchack, Robert Cenin, Danielle A. Patel, Seema Lo, Mimi Schlafer, Danielle Li, Belinda K. T. Donald Harvey III, R. Wasef, Bestis Ying, Jian Kovacsovics, Tibor Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia |
| title | Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia |
| title_full | Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia |
| title_fullStr | Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia |
| title_full_unstemmed | Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia |
| title_short | Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in FLT3-mutated acute myeloid leukemia |
| title_sort | efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in flt3-mutated acute myeloid leukemia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690909/ https://www.ncbi.nlm.nih.gov/pubmed/37345485 http://dx.doi.org/10.3324/haematol.2022.281967 |
| work_keys_str_mv | AT leejulias efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT wagnercharlotteb efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT prelewiczstacy efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT kurishheenap efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT walchackrobert efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT cenindaniellea efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT patelseema efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT lomimi efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT schlaferdanielle efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT libelindakt efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT donaldharveyiiir efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT wasefbestis efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT yingjian efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia AT kovacsovicstibor efficacyandtoxicityofmidostaurinwithidarubicinandcytarabineinductioninflt3mutatedacutemyeloidleukemia |